ACETYGEN

Serial Number 88160479
Registration 5933638
702

Registration Progress

Application Filed
Oct 18, 2018
Under Examination
Apr 16, 2019
Approved for Publication
Feb 19, 2019
Published for Opposition
Feb 19, 2019
Registered
Dec 10, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-10)
Due: Dec 10, 2025 141 days

Trademark Image

ACETYGEN

Basic Information

Serial Number
88160479
Registration Number
5933638
Filing Date
October 18, 2018
Registration Date
December 10, 2019
Published for Opposition
February 19, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
May 9, 2025
Registration
Registered
Classes
001

Rights Holder

Biocogent, LLC

16
Address
25 Health Sciences Drive
Stony Brook, NY 11790

Ownership History

Biocogent, LLC

Original Applicant
16
Stony Brook, NY

Biocogent, LLC

Owner at Publication
16
Stony Brook, NY

Biocogent, LLC

Original Registrant
16
Stony Brook, NY

Legal Representation

Attorney
Anthony R Barkume

USPTO Deadlines

Next Deadline
141 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-10)
Due Date
December 10, 2025
Grace Period Ends
June 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
May 9, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
May 9, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
May 9, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 17, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 10, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Feb 3, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 10, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 6, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 5, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 30, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 30, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 15, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 15, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 16, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 16, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 19, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 30, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 14, 2019 ALIE A ASSIGNED TO LIE Loading...
Dec 20, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 20, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 20, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 20, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 20, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 22, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Bio-active preparations containing tea extracts having anti-inflammatory, anti-fibrotic, anti-microbial, and histone de-acetylase inhibitor properties/functionalities for use as ingredients in the manufacture of cosmetics and personal care products
First Use Anywhere: Oct 15, 2019
First Use in Commerce: Oct 15, 2019

Classification

International Classes
001